DrugPatentWatch Database Preview
Details for Patent: 10,201,542
» See Plans and Pricing
Which drugs does patent 10,201,542 protect, and when does it expire?
Patent 10,201,542 protects VIEKIRA PAK (COPACKAGED) and is included in one NDA.
This patent has sixteen patent family members in ten countries.
Summary for Patent: 10,201,542
| Title: | Formulations of pyrimidinedione derivative compounds |
| Abstract: | The present disclosure relates to pharmaceutical compositions of pyrimidinedione derivative compounds and methods of preparing and uses thereof. The disclosure also relates to methods of enhancing bioavailability of pyrimidinedione derivative compounds in pharmaceutical compositions administered to a subject and methods of reducing the amount of a pyrimidinedione derivative compound in a pharmaceutical composition while achieving the same bioavailability in a subject. |
| Inventor(s): | Li; Yanxia (Libertyville, IL), Gao; Ping (Highland Park, IL), Shi; Yi (Libertyville, IL), Zhang; Geoff G. (Vernon Hills, IL), Gao; Yi (Vernon Hills, IL), Wu; Jianwei (Potomac, MD) |
| Assignee: | AbbVie Inc. (North Chicago, IL) |
| Application Number: | 15/455,477 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Process; Dosage form; |
Drugs Protected by US Patent 10,201,542
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir | TABLET, TABLET;ORAL | 206619-001 | Dec 19, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | TREATMENT OF HCV INFECTION USING DASABUVIR | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,201,542
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013330993 | Start Trial | |||
| Brazil | 112015008927 | Start Trial | |||
| Canada | 2888883 | Start Trial | |||
| China | 104853752 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
